Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionmethylated histone binding

ZCWPW1 PWWP2A

5.05e-048682GO:0035064
GeneOntologyMolecularFunctionmethylation-dependent protein binding

ZCWPW1 PWWP2A

5.28e-048882GO:0140034
GeneOntologyMolecularFunctionmodification-dependent protein binding

ZCWPW1 PWWP2A

2.85e-0320682GO:0140030
GeneOntologyMolecularFunctionhistone binding

ZCWPW1 PWWP2A

4.66e-0326582GO:0042393
GeneOntologyBiologicalProcessacrosome assembly

MFSD14A PLA2G3

8.24e-053682GO:0001675
GeneOntologyBiologicalProcessspermatogenesis

BSCL2 MFSD14A PLA2G3 ZCWPW1

1.05e-0474484GO:0007283
GeneOntologyBiologicalProcessphosphatidic acid metabolic process

BSCL2 PLA2G3

1.07e-044182GO:0046473
GeneOntologyBiologicalProcessmale gamete generation

BSCL2 MFSD14A PLA2G3 ZCWPW1

1.15e-0476284GO:0048232
GeneOntologyBiologicalProcessspermatid differentiation

BSCL2 MFSD14A PLA2G3

1.21e-0427283GO:0048515
GeneOntologyBiologicalProcessgamete generation

BSCL2 MFSD14A PLA2G3 ZCWPW1

3.06e-0498284GO:0007276
GeneOntologyBiologicalProcesssecretory granule organization

MFSD14A PLA2G3

3.90e-047882GO:0033363
GeneOntologyBiologicalProcessmulticellular organismal reproductive process

BSCL2 MFSD14A PLA2G3 ZCWPW1

6.48e-04119484GO:0048609
GeneOntologyBiologicalProcessdevelopmental process involved in reproduction

BSCL2 MFSD14A PLA2G3 ZCWPW1

7.37e-04123584GO:0003006
GeneOntologyBiologicalProcesscellular process involved in reproduction in multicellular organism

BSCL2 MFSD14A PLA2G3

8.44e-0452783GO:0022412
GeneOntologyBiologicalProcesssexual reproduction

BSCL2 MFSD14A PLA2G3 ZCWPW1

9.27e-04131284GO:0019953
GeneOntologyBiologicalProcesscellular component assembly involved in morphogenesis

MFSD14A PLA2G3

1.54e-0315682GO:0010927
GeneOntologyBiologicalProcesscellular anatomical entity morphogenesis

MFSD14A PLA2G3

1.54e-0315682GO:0032989
MousePhenoabnormal spermiogenesis

BSCL2 MFSD14A PLA2G3

9.27e-0523763MP:0001932
MousePhenoabnormal sperm head morphology

BSCL2 MFSD14A PLA2G3

1.23e-0426163MP:0009230
MousePhenoabnormal gametes

BSCL2 MFSD14A PLA2G3 ZCWPW1

1.35e-0478564MP:0001124
MousePhenoabnormal sperm flagellum morphology

BSCL2 MFSD14A PLA2G3

1.77e-0429563MP:0008892
MousePhenoabnormal male germ cell morphology

BSCL2 MFSD14A PLA2G3 ZCWPW1

1.92e-0485964MP:0006362
MousePhenoabnormal spermatogenesis

BSCL2 MFSD14A PLA2G3 ZCWPW1

2.41e-0491064MP:0001156
MousePhenoabnormal germ cell morphology

BSCL2 MFSD14A PLA2G3 ZCWPW1

2.80e-0494664MP:0002208
MousePhenoabnormal foam cell morphology

BSCL2 MFSD14A PLA2G3 ZCWPW1

2.89e-0495464MP:0009840
MousePhenoabnormal motile cilium morphology

BSCL2 MFSD14A PLA2G3

3.47e-0437063MP:0013206
MousePhenoglobozoospermia

MFSD14A PLA2G3

4.09e-047462MP:0002686
MousePhenoabnormal gametogenesis

BSCL2 MFSD14A PLA2G3 ZCWPW1

4.52e-04107064MP:0001929
MousePhenoteratozoospermia

BSCL2 MFSD14A PLA2G3

4.62e-0440863MP:0005578
MousePhenoabnormal phospholipid level

BSCL2 PLA2G3

4.78e-048062MP:0004777
MousePhenoabnormal cilium morphology

BSCL2 MFSD14A PLA2G3

5.51e-0443363MP:0013202
MousePhenoabnormal acrosome assembly

MFSD14A PLA2G3

6.32e-049262MP:0031354
MousePhenoabnormal sperm mitochondrial sheath morphology

MFSD14A PLA2G3

6.73e-049562MP:0009832
MousePhenoabnormal male reproductive system physiology

BSCL2 MFSD14A PLA2G3 ZCWPW1

1.04e-03132964MP:0003698
MousePhenoabnormal internal male genitalia morphology

BSCL2 MFSD14A PLA2G3 ZCWPW1

1.25e-03139264MP:0009205
MousePhenoabnormal male reproductive system morphology

BSCL2 MFSD14A PLA2G3 ZCWPW1

1.33e-03141564MP:0001145
MousePhenoabnormal male genitalia morphology

BSCL2 MFSD14A PLA2G3 ZCWPW1

1.33e-03141564MP:0009198
MousePhenoabnormal body temperature

BSCL2 PLA2G3

1.39e-0313762MP:0005535
MousePhenoabnormal sperm midpiece morphology

MFSD14A PLA2G3

1.54e-0314462MP:0009831
MousePhenoabnormal sperm number

BSCL2 MFSD14A ZCWPW1

1.60e-0362463MP:0002673
MousePhenodecreased male germ cell number

BSCL2 MFSD14A ZCWPW1

1.72e-0364063MP:0004901
MousePhenoabnormal acrosome morphology

MFSD14A PLA2G3

1.87e-0315962MP:0008898
MousePhenodecreased germ cell number

BSCL2 MFSD14A ZCWPW1

2.11e-0368763MP:0002209
MousePhenodecreased total retina thickness

BSCL2 CTSH

2.86e-0319762MP:0011965
MousePhenoabnormal cell differentiation

BSCL2 PLA2G3 ZCWPW1

3.22e-0379563MP:0005076
DomainPWWP

ZCWPW1 PWWP2A

3.04e-052082SM00293
DomainPWWP

ZCWPW1 PWWP2A

4.04e-052382PF00855
DomainPWWP_dom

ZCWPW1 PWWP2A

4.04e-052382IPR000313
DomainPWWP

ZCWPW1 PWWP2A

4.41e-052482PS50812
GeneFamilyPWWP domain containing

ZCWPW1 PWWP2A

2.11e-0522621147
ToppCellfacs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GABBR2 PLA2G3

2.55e-04137824dcb15de821439011df1bb0bbd7682d674bd725d
ToppCellfacs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GABBR2 PLA2G3

2.55e-0413782c05ceeb7b483324604cb3f647d2da2b3786071b1
ToppCellE16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass

PLA2G3 CTSH

3.26e-04155829cad73d0b8ead289e1073d1a2e00bbeb1228308c
ToppCelldroplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ZCWPW1 CTSH

3.51e-041618298be0cf8228496b31f7f3e0efd8787e95eb626d1
ToppCelldroplet-Lung-immune-endo-depleted-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZCWPW1 MRPS18B

3.51e-0416182249c2b97cc25de5053f5048ee354615df49b2081
ToppCelldroplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ZCWPW1 CTSH

3.51e-04161827af3b0d4fc7967f6b3e2d255d23fd8b1fd01a7af
ToppCellfacs-Lung-Endomucin-24m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GABBR2 CTSH

3.60e-04163822a561aa4518cf52d8470eff083b84f942a2b2b5d
ToppCellfacs-Lung-Endomucin-24m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GABBR2 CTSH

3.73e-04166826842735750dcb361e4c9844f05233b0fbb879652
ToppCellPND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ZCWPW1 MRPS18B

3.82e-0416882cc0dd43d5cda01e643d8e8d74ec7617d61890760
ToppCelldroplet-Heart-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BSCL2 CTSH

3.87e-04169822e5bb6437bc9c614e337c5ffb6f6457cd9fc7f4c
ToppCellPND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

GABBR2 ZCWPW1

3.87e-0416982563c267edaade0e5df192ad953801ef9768d4270
ToppCelldroplet-Heart-nan-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BSCL2 CTSH

4.10e-0417482cf4e0567f2a4ebe5534046b1c091af59b55bdc4f
ToppCelldroplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

BSCL2 CTSH

4.34e-0417982fa58fa0901eadb170e3d2facb2a3d8c5e624329a
ToppCelldroplet-Lung-18m-Hematologic-myeloid-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

BSCL2 CTSH

4.34e-041798266afd54428e6dcadc3e341faecfde42be4fb5905
ToppCelldroplet-Lung-21m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ZCWPW1 CTSH

4.63e-04185824c55fa96877ab9a00fcbec3fb70fd2208d222527
ToppCelldroplet-Lung-21m-Hematologic-lymphocytic-Zbtb32+_B_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ZCWPW1 CTSH

4.63e-04185825fd4a3776259c96cf2dcb87f050af8226acbbda9
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PLA2G3 CTSH

5.14e-0419582643a360d3358bad52f0737c0d55195b69007c29b
ToppCellMild|World / Condition, Lineage, Cell class and cell subclass

BSCL2 MRPS18B

5.25e-0419782476b0d0389f9fcd4614f6bb1f494281f467f6730
ToppCellCaecum-(2)_B_cell-(21)_B_cell_IgG_Plasma|Caecum / shred on region, Cell_type, and subtype

BSCL2 CTSH

5.30e-04198823893fcfc1de5937be3ccc7e545f711f2c95a2827
ToppCellCaecum-B_cell-B_cell_IgG_Plasma|Caecum / Region, Cell class and subclass

BSCL2 CTSH

5.30e-0419882d8cb78b1763710a158cf22b59aebaa44afd2374c
ToppCellBiopsy_Control_(H.)|World / Sample group, Lineage and Cell type

BSCL2 MFSD14A

5.36e-0419982254c255292d9810fcea017526eae5ddb3a465ce3
DrugMetergoline [17692-51-2]; Up 200; 10uM; MCF7; HT_HG-U133A

GABBR2 PLA2G3 ZCWPW1

3.16e-05191835344_UP
DrugOzagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; MCF7; HT_HG-U133A

GABBR2 PLA2G3 ZCWPW1

3.36e-05195833503_DN
DrugN6-methyladenosine [1867-73-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A

BSCL2 PLA2G3 ZCWPW1

3.46e-05197835332_DN
DrugBrompheniramine maleate [980-71-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A

GABBR2 PLA2G3 ZCWPW1

3.57e-05199833271_UP
DrugCefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; HL60; HT_HG-U133A

GABBR2 PLA2G3 ZCWPW1

3.62e-05200832988_DN
Drugclonazepam

GABBR2 CTSH

3.54e-048282CID000002802
DrugGDP-b-S

GABBR2 BSCL2

1.37e-0316282CID000643998
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A

GABBR2 PLA2G3

1.60e-03175825222_UP
DrugPrenylamine lactate [69-43-2]; Up 200; 9.6uM; PC3; HT_HG-U133A

GABBR2 ZCWPW1

1.69e-03180825070_UP
DrugMetergoline [17692-51-2]; Up 200; 10uM; MCF7; HT_HG-U133A

GABBR2 PLA2G3

1.74e-03183823221_UP
DrugTTNPB; Up 200; 0.1uM; MCF7; HG-U133A

GABBR2 ZCWPW1

1.88e-0319082223_UP
DrugNitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; PC3; HT_HG-U133A

GABBR2 ZCWPW1

1.92e-03192827382_UP
DrugDicumarol [66-76-2]; Up 200; 11.8uM; HL60; HT_HG-U133A

GABBR2 PLA2G3

1.92e-03192822561_UP
DrugGalanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; HL60; HT_HG-U133A

GABBR2 BSCL2

1.94e-03193822131_UP
DrugProcaine hydrochloride [51-05-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A

GABBR2 PLA2G3

1.94e-03193825430_DN
DrugCarisoprodol [78-44-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A

PLA2G3 ZCWPW1

1.94e-03193823251_UP
DrugGriseofulvin [126-07-8]; Down 200; 11.2uM; HL60; HT_HG-U133A

GABBR2 BSCL2

1.94e-03193822332_DN
DrugSkimmianine [83-95-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A

GABBR2 ZCWPW1

1.96e-03194826242_UP
DrugLevocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A

GABBR2 PLA2G3

1.96e-03194823509_DN
DrugBenzethonium chloride [121-54-0]; Up 200; 9uM; HL60; HT_HG-U133A

GABBR2 PLA2G3

1.98e-03195822508_UP
DrugRaloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; MCF7; HT_HG-U133A

GABBR2 PLA2G3

1.98e-03195826235_UP
DrugIpratropium bromide [22254-24-6]; Down 200; 9.8uM; MCF7; HT_HG-U133A

PLA2G3 ZCWPW1

1.98e-03195822762_DN
Drugikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA

GABBR2 PLA2G3

1.98e-0319582866_UP
DrugIsopropamide iodide [71-81-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A

PLA2G3 ZCWPW1

1.98e-03195823461_DN
DrugPicotamide monohydrate [80530-63-8]; Up 200; 10.2uM; PC3; HT_HG-U133A

GABBR2 ZCWPW1

1.98e-03195827140_UP
DrugMetoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; PC3; HT_HG-U133A

GABBR2 ZCWPW1

1.98e-03195824508_DN
DrugChlorogenic acid [327-97-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A

GABBR2 PLA2G3

1.98e-03195823282_UP
DrugPipenzolate bromide [125-51-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A

GABBR2 PLA2G3

1.98e-03195826821_DN
DrugSulfamerazine [127-79-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A

GABBR2 PLA2G3

1.98e-03195824740_DN
DrugChicago sky blue 6B [2610-05-1]; Down 200; 4uM; PC3; HT_HG-U133A

GABBR2 ZCWPW1

1.98e-03195826626_DN
DrugPyrimethamine [58-14-0]; Down 200; 16uM; MCF7; HT_HG-U133A

GABBR2 PLA2G3

2.00e-03196824779_DN
DrugPalmatine chloride [3486-67-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A

PLA2G3 ZCWPW1

2.00e-03196822795_DN
Drugalpha-estradiol; Up 200; 0.01uM; HL60; HT_HG-U133A

GABBR2 PLA2G3

2.00e-03196822670_UP
DrugFluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A

GABBR2 PLA2G3

2.00e-03196823314_UP
DrugSulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; HL60; HT_HG-U133A

GABBR2 PLA2G3

2.00e-03196822560_UP
DrugPiperine [94-62-2]; Up 200; 14uM; MCF7; HT_HG-U133A

PLA2G3 ZCWPW1

2.00e-03196823263_UP
DrugBezafibrate [41859-67-0]; Down 200; 11uM; PC3; HT_HG-U133A

GABBR2 ZCWPW1

2.00e-03196826653_DN
DrugPyrithyldione [77-04-3]; Up 200; 24uM; HL60; HT_HG-U133A

GABBR2 PLA2G3

2.00e-03196822740_UP
DrugChloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A

GABBR2 ZCWPW1

2.00e-03196823350_DN
DrugMethyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; MCF7; HT_HG-U133A

GABBR2 ZCWPW1

2.00e-03196827360_DN
Drugclozapine; Up 200; 10uM; MCF7; HT_HG-U133A

GABBR2 PLA2G3

2.00e-03196825226_UP
Drugindomethacin, USP; Down 200; 20uM; MCF7; HG-U133A

GABBR2 ZCWPW1

2.00e-0319682262_DN
DrugLumicolchicine gamma [6901-14-0]; Down 200; 10uM; PC3; HT_HG-U133A

GABBR2 ZCWPW1

2.00e-03196824195_DN
DrugChlorambucil [305-03-3]; Up 200; 13.2uM; PC3; HT_HG-U133A

GABBR2 ZCWPW1

2.00e-03196824523_UP
DrugClidinium bromide [3485-62-9]; Up 200; 9.2uM; HL60; HT_HG-U133A

GABBR2 PLA2G3

2.00e-03196822734_UP
DrugProcyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; HL60; HT_HG-U133A

GABBR2 PLA2G3

2.00e-03196822991_DN
DrugMimosine [500-44-7]; Down 200; 20.2uM; PC3; HT_HG-U133A

GABBR2 ZCWPW1

2.00e-03196826703_DN
DrugGliclazide [21187-98-4]; Up 200; 12.4uM; PC3; HT_HG-U133A

PLA2G3 ZCWPW1

2.02e-03197825089_UP
DrugPromethazine hydrochloride [58-33-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A

GABBR2 PLA2G3

2.02e-03197825317_UP
Drugclofibrate; Down 200; 150uM; MCF7; HG-U133A

GABBR2 ZCWPW1

2.02e-0319782263_DN
DrugEucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; HL60; HT_HG-U133A

GABBR2 PLA2G3

2.02e-03197822556_UP
DrugMeropenem [96036-03-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A

GABBR2 ZCWPW1

2.02e-03197827180_UP
Drug2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A

PLA2G3 ZCWPW1

2.02e-03197825600_DN
DrugTubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; MCF7; HT_HG-U133A

GABBR2 PLA2G3

2.02e-03197825449_DN
DrugEtidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; HL60; HT_HG-U133A

PLA2G3 ZCWPW1

2.02e-03197822985_DN
DrugClidinium bromide [3485-62-9]; Down 200; 9.2uM; PC3; HT_HG-U133A

GABBR2 ZCWPW1

2.02e-03197824499_DN
DrugThonzonium bromide [553-08-2]; Up 200; 6.8uM; HL60; HT_HG-U133A

GABBR2 ZCWPW1

2.02e-03197823080_UP
DrugPridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A

PLA2G3 ZCWPW1

2.02e-03197823456_DN
DrugOrphenadrine hydrochloride [341-69-5]; Down 200; 13uM; PC3; HT_HG-U133A

GABBR2 ZCWPW1

2.02e-03197823801_DN
DrugHydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; PC3; HT_HG-U133A

GABBR2 ZCWPW1

2.02e-03197822119_UP
DiseaseAlzheimer disease

ZCWPW1 CTSH

5.36e-0348572MONDO_0004975
Diseasecognitive decline measurement

GABBR2 ZCWPW1

5.38e-0348672EFO_0007710
Diseaseplatelet component distribution width

ZCWPW1 PWWP2A

1.26e-0275572EFO_0007984
Diseaseplatelet crit

ZCWPW1 PWWP2A

1.96e-0295272EFO_0007985
Diseasesmoking status measurement

GABBR2 BSCL2

2.84e-02116072EFO_0006527

Protein segments in the cluster

PeptideGeneStartEntry
AWYGFGSEPWMMWAA

MFSD14A

326

Q96MC6
YWIVKNSWGPQWGMN

CTSH

296

P09668
KYQWIIPGWYEPSWW

GABBR2

276

O75899
LFSYMQWVWGGIWPR

BSCL2

251

Q96G97
GDIVWAKIYGFPWWP

PWWP2A

656

Q96N64
WYWWGGCRMYGTVPL

PLA2G3

256

Q9NZ20
GDPWYPWYNWKQPPE

MRPS18B

196

Q9Y676
IWAKQYGYPWWPGMI

ZCWPW1

321

Q9H0M4